The Inter-Institutional Pilot Project Awards promote collaboration across the Clinical and Translational Science Award (CTSA) consortium by funding innovative, translational research projects that involve three or more of the six CTSA institutions that make up the CORES Research Collaborative: University of New Mexico Health Sciences Center; University of Kansas Medical Center; University of Kentucky; University of Arkansas for Medical Sciences; University of Iowa; and the University of Utah Health.
In accordance with the National Institutes of Health (NIH) strategic plan and its commitment to increasing representation in research, funding priority for this RFA will be given to research that addresses issues of disparities either because of rurality or underrepresented and disadvantaged groups.
Rurality includes individuals living in rural or frontier communities.
Underrepresented and disadvantaged groups include:
- Ethnic groups that have been shown to be underrepresented in biomedical research: Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders.
- Individuals with disabilities.
- Individuals from disadvantaged backgrounds.
For more information and expanded definitions, please see the NIH's statement on Underrepresented Populations in the U.S. Biomedical, Clinical Behavioral and Social Science Enterprise.
Involvement of these groups is not a requirement for funding, but projects which address health concerns that disproportionately affect one or more of these groups, or projects that seek to apply or test general treatments to one of more of these groups are preferred.
CTSA Inter-Institutional Pilot Project Award Request for Applications
The 2022-2023 CORES CTSA Inter-Institutional Pilot Project Award application timeline:
- LOI and Draft Aims Due Date: February 14, 2022
- Application Due Date: March 14, 2022
If you have questions, please contact Jen Baker, Frontiers Administrative Director, at email@example.com.
Dec 14, 2021